Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synovitis Granules for knee osteoarthritis
ChiCTR-IPR-17011954Phase 4Recruiting
- Sponsor
- The Third Hospital of Hebei Medical University
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Synovitis Granules in knee osteoarthritis (OA) (2 arms), sponsored by The Third Hospital of Hebei Medical University. Primary endpoints: Kellgren-Lawrence and WOMAC. Started Jul 2017; status: recruiting.
02
Drugs
Synovitis Granules
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IPR-17011954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011954.